Pedro Martinez-Clark, M.D.

Triple board certified: Cardiovascular disease & internal medicine

Internationally renowned physician in South Florida. Originally from Colombia, S.A., Dr. Martinez-Clark established his medical practice in Miami in 2008 after completing his training at Case Western Reserve University and the Beth Israel Deaconess Medical Center/Harvard Medical School. With board certifications in internal medicine, cardiovascular medicine, and interventional cardiology Dr. Martinez-Clark has developed an international practice and has positioned himself as one of the top cardiologists in the region.

Pedro Martinez-Clark is a world-renowned physician in Miami, Florida. Having earned his medical degree at Colombia’s acclaimed Universidad del Norte in the city of Barranquilla, Pedro traveled to Ohio’s Case Western Reserve University to begin his post-graduate medical training in Internal Medicine. Having excelled and made a name for himself in the northeast, Dr. Martinez-Clark placed into one of the United States’ most competitive Clinical Fellowships in Cardiovascular Disease (Cardiology), at Beth Israel Deaconess Medical Center, Harvard Medical School. At Harvard, he obtained further fellowship training in Interventional Cardiology, Endovascular Therapies and Vascular Medicine. During his stay at Harvard, Dr. Martinez-Clark participated in many clinical trials, research projects and started his involvement in medical device innovation.  It would be no surprise that 8 years later, Dr. Martinez-Clark would become recognized, globally for excellence in medical care, research efforts and medical innovation contributions. In addition to caring for patients, Dr. Martinez-Clark works very closely with several public and private organizations with the common goal of improving the healthcare innovation ecosystem in South Florida.

From the medical innovation perspective, Dr. Martinez-Clark has been involved in several medical device development efforts. Some of these technologies include:

  • Microprocessor controlled percutaneous aortic valve replacement which allows unparalleled precision and low tissue-device contact force at the time of implantation. This project has completed chronic animal experiments and is currently undergoing a second round of funding in order to start human trials.

  • Percutaneous annuloplasty for the treatment of functional mitral regurgitation in patients with heart failure. The global clinical trial has been completed and the data has been submitted to the European Committee for device registration.  

  • Trans-Apical annuloplasty for the treatment of functional mitral regurgitation using a hybrid combined approach of surgical and percutaneous techniques. Feasibility study in humans has been completed.

  • One of the original researchers that described the transcaval access to the cardiovascular system, a novel percutaneous approach that allows patients with peripheral vascular disease undergo percutaneous procedures with minimal risk. Dr. Martinez-Clark co-founded TransCaval Solutions, Inc., a medical device company dedicated to create purpose built access and closure technology that facilitates the transcaval access. The technique won the Best of the Best Abstract Award at The Society for Cardiovascular Angiography and Interventions (SCAI)'s 2014 meeting. Dr. Martinez-Clark obtained funding from private investors to develop and market his medical device to treat over 154,000 patients annually who can not be treated with conventional technical devices, thus creating a $ 2.2 billion market opportunity in 2020.

  • Corquest Inc., percutaneous access to the right atrium with application in structural heart disease. This technology was tested in animals and cadavers and was sold to Cardio3, a medical device company from Belgium in the regenerative medicine space.

  • Pioneer in percutaneous aortic valve replacement in South Florida.
    Co-developed several cardiovascular technologies and procedures.

  • Winner of the “best research award” at the 2014 SCAI meeting.

  • Winner of the Life Sciences South Florida's Lifees Award at eMerge Americas 2016.

  • Past medical director for Syntheon, LLC —a medical device firm in South Florida.

  • Co-founder of Miami MedTech, the first Miami-based healthcare incubator for medical technologies.

  • Founder and medical advisor of bioaccess (formerly Interventional Concepts, Inc.), a contract research organization for early-stage Medtech startups.

  • Founder and CEO of Amavita Heart and Vascular Health, the largest cardiovascular medical practice in South Florida.

  • International speaker, author of numerous juried and indexed journal publications, and co-author of the Hurst medical textbook chapter on systems of care for primary angioplasty.